Advanced Oncotherapy – Director Dealing and Award of Options

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Dr Enrico Vanni, a Non-Executive Director of the Company, had on 14th July purchased 1,000,000 ordinary shares of 1 penny each in the Company at 7.9 pence per Ordinary Share. Following this transaction, Dr Vanni now holds 14,050,000 Ordinary Shares representing 1.02% of […]

Advanced Oncotherapy – Birmingham University Supporting Cancer Treatment Research

The University of Birmingham is supporting ground-breaking research to create a proton Computed Tomography (CT) image that will help to facilitate the treatment of cancer patients in the UK. The researchers are using the University’s centrally funded HPC service, which was built by OCF, to simulate 1000 million protons, which takes just 3% of the time […]

Advanced Oncotherapy – Exercise of Warrants and Issue of Shares

Exercise of Warrants and Issue of Shares. Issue of Shares Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has today issued 600,000 new ordinary shares of 1p in the Company at a subscription price of 8 pence per Ordinary Share to Dr Enrico Vanni, a non-executive director, […]

Advanced Oncotherapy – US cancer treatment centre targets China for proton therapy

US cancer treatment centre targets China for proton therapy In its efforts to attract more international cancer patients to Jacksonville, the University of Florida Health Proton Therapy Institute has held its first-ever symposium in China. Representatives for the institute had a two-week visit to China where they met with health care providers to talk about […]

Advanced Oncotherapy – Holdings in company

Changes to the holding of Mr Alberto Colussi of Brahma AG has resulted in his direct voting shareholding falling from 242,689,600 shares to 27,879,630 voting shares (2.026%) and 214,809,970 shares (15.606%)

Advanced Oncotherapy – Brain tumour boy Ashya King back home in Portsmouth

From the BBC website. Brain tumour boy Ashya King back home in Portsmouth. A boy who was at the centre of an international manhunt after his parents took him abroad for brain tumour treatment is back home in Portsmouth. Brett and Naghemeh King took six-year-old Ashya out of a Southampton hospital against medical advice last […]

Advanced Oncotherapy – SCDTL testing commences, marking the completion of a further key milestone in LIGHT system development

Commencement of initial SCDTL testing Completion of further key milestone in the development of the LIGHT System Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that the first tests have begun on the Side Coupled Drift Tube Linac, in line with the Company’s expected timetable. The SCDTL modules are […]

Advanced Oncotherapy – Director Dealing & Total Voting Rights

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, has been informed that Michael Sinclair, Executive Chairman of the Company, has yesterday sold 7 million ordinary shares of 1 penny each in the Company at 8.25 pence per Share in order to fund the exercise of warrants over 28.5 million Shares […]

Advanced Oncotherapy – Bloomberg Business – RNCOS – Business Consultancy Services: US Proton Therapy Market Outlook 2020

Bloomberg Business – RNCOS – Business Consultancy Services: US Proton Therapy Market Outlook 2020. M2 Communications In light of an alarmingly rising incidence of cancers and limited treatment options, physicians are being forced to look beyond conventional treatments. In such a scenario, Proton Therapy, the most advanced radiation technique available, is being projected as the […]